SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION vs LINQ II Insertable Cardiac Monitor

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

by DIACOUSTIC MEDICAL DEVICES (PTY)

LINQ II Insertable Cardiac Monitor

by Medtronic

AI Verdict

Tool A is designed for real-time diagnostic assistance with heart murmurs using acoustic analysis from an external stethoscope. In contrast, Tool B provides long-term, continuous heart rhythm monitoring for arrhythmias via an insertable cardiac device. While both leverage AI in cardiology, their distinct focus on different cardiac conditions and monitoring methodologies makes them suitable for different clinical scenarios.

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if…

Choose SensiCardiac Mobi if you need an immediate, point-of-care AI-powered tool to assist in the initial diagnosis and differentiation of heart murmurs. This mobile application is ideal for physicians looking to quickly analyze acoustic heart signals from an electronic stethoscope to distinguish between physiological and pathological sounds, complementing their clinical assessment.

View SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION →

Choose LINQ II Insertable Cardiac Monitor if…

Choose the Medtronic LINQ II if your patient requires long-term, continuous monitoring for suspected intermittent arrhythmias that are difficult to capture with traditional methods. This insertable cardiac monitor offers up to 4.5 years of monitoring, remote programming capabilities, and AI-powered accuracy, making it suitable for comprehensive arrhythmia diagnosis and management, including in pediatric patients.

View LINQ II Insertable Cardiac Monitor →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	LINQ II Insertable Cardiac Monitor
Pricing	Contact for pricing	Enterprise
Deployment	Hosted server environment (Linux OS) with a mobile application interface	Hybrid
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

SensiCardiac Mobi offers a mobile application for physicians to acquire, record, and analyze heart sounds at the point of care, integrating directly into a physical examination. This provides immediate diagnostic support through a user-friendly mobile interface. While Tool B involves a patient-facing app, Tool A's direct physician interaction for real-time diagnosis gives it an edge in point-of-care usability.

Clinical Value

LINQ II Insertable Cardiac Monitor

The Medtronic LINQ II provides long-term, continuous heart rhythm monitoring for up to 4.5 years, utilizing AI algorithms for enhanced accuracy in diagnosing elusive arrhythmias. Its ability to capture intermittent events over extended periods offers a more comprehensive and critical diagnostic capability compared to Tool A's point-of-care murmur assessment. This continuous monitoring is crucial for conditions that might otherwise be missed.

Pricing & Value

Tie

Both SensiCardiac Mobi and Medtronic LINQ II state that pricing information is not publicly available and requires direct contact or enterprise negotiation. Without any disclosed pricing details or comparative cost-effectiveness studies, it is impossible to determine which tool offers better value. Therefore, this dimension is a tie.

Enterprise Readiness

LINQ II Insertable Cardiac Monitor

Medtronic LINQ II, backed by a global medical device leader, demonstrates superior enterprise readiness with its proven track record of over 1 million patients worldwide and a target market ranging from solo practices to large health systems. Its HIPAA compliance and hybrid deployment options further enhance its suitability for diverse healthcare environments. Tool A, while HIPAA compliant, does not provide comparable evidence of large-scale deployment or organizational maturity.

Innovation

LINQ II Insertable Cardiac Monitor

The Medtronic LINQ II represents a higher degree of innovation by combining an insertable cardiac monitor with advanced AI algorithms (AccuRhythmu2122 AI, innovative PVC detection), remote programming, and an extended monitoring duration of up to 4.5 years. This integration of invasive technology with sophisticated AI for long-term, continuous, and remote arrhythmia detection is a more complex and impactful advancement in cardiac diagnostics. Tool A's mobile AI for murmur diagnosis is innovative for point-of-care, but less so than an implanted, long-duration, AI-driven monitor.

Support & Docs

LINQ II Insertable Cardiac Monitor

Medtronic, as a large and established medical device company, provides extensive and readily accessible support resources, including detailed clinician manuals, patient education materials, online resources, and dedicated patient and technical service specialists. While SensiCardiac Mobi has user manuals available, Medtronic's global infrastructure and comprehensive documentation for both professionals and patients demonstrate a significantly more robust support ecosystem.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	LINQ II Insertable Cardiac Monitor
Name	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	LINQ II Insertable Cardiac Monitor
Company	DIACOUSTIC MEDICAL DEVICES (PTY)	Medtronic
Primary Diagnostic/Monitoring Focus	Assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals to differentiate between physiological and pathological sounds.	Long-term, continuous heart rhythm monitoring with remote programming and enhanced accuracy for diagnosing arrhythmias.
AI-Powered Feature	AI-powered mobile application that assists physicians in diagnosing heart murmurs; analyzes heart sounds using the Sensi Diagnostic Heart Murmur Algorithm.	AI-powered insertable cardiac monitor providing enhanced accuracy for diagnosing arrhythmias; utilizes AccuRhythmu2122 AI algorithms.
Mobile Application Role	Mobile application for data capture and display (e.g., iPhone 4S or later).	MyCareLink Heartu2122 mobile app for data transmission.
Specialties	Cardiology, Internal Medicine, Pediatrics	Cardiology

Videos

Demos, reviews, and walkthroughs featuring SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION and LINQ II Insertable Cardiac Monitor.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into a physician's existing clinical workflow, and for which patient populations are they most appropriate?

SensiCardiac Mobi is a point-of-care diagnostic aid, used during a physical exam with an electronic stethoscope to differentiate heart murmurs in real-time for cardiology, internal medicine, and pediatric patients. The LINQ II is an insertable device for long-term, continuous heart rhythm monitoring, primarily for cardiology patients experiencing infrequent symptoms like dizziness, palpitations, syncope, or chest pain, or those at risk for arrhythmias, including pediatric patients aged two and older.

What specific metrics or clinical evidence support the accuracy and sensitivity claims for each tool in their respective diagnostic areas?

SensiCardiac Mobi's algorithm distinguishes between physiological and pathological heart murmurs, with reported accuracy above 95% in murmur detection. The LINQ II's AccuRhythm AI algorithms significantly reduce false alerts for atrial fibrillation (AF) by 88.2% and pause events by 97.4%, while preserving 99% of true AF alerts and 100% of true pause alerts, based on real-world patient data.

What is the expected learning curve for physicians and their staff to effectively utilize each tool, and what is the typical time-to-value for integrating them into practice?

SensiCardiac Mobi, as a mobile application used with an e-stethoscope, likely has a relatively quick learning curve, with its user interface being nearly identical to a previously cleared version. The LINQ II involves a minimally invasive insertion procedure and remote management, with Medtronic offering educational resources for both insertion and follow-up, suggesting a more involved but supported learning process.

What kind of ongoing support and training can be expected for each tool, and are there opportunities to connect with existing physician users for peer insights?

Medtronic provides extensive support for LINQ II, including technical and patient services, order placement, reimbursement assistance, and patient registration support, with dedicated phone lines. While specific details for SensiCardiac Mobi's ongoing support are not provided, its company, Diacoustic Medical Devices, offers white papers on product functionality.

Beyond standard compliance, what specific security measures are in place to protect patient data during transmission and storage for each tool, and what audit trail capabilities are available for clinical review?

SensiCardiac Mobi operates on a hosted server environment, and data is uploaded via its mobile app to a HIPAA-compliant server for analysis. The LINQ II utilizes secure, two-way communication via Bluetooth for data transmission to the Medtronic CareLink Network, and remote monitoring systems generally employ encrypted channels, user access controls, and audit trails for traceability and compliance.

What are the key considerations for successfully implementing and scaling each tool across multiple clinical sites or a larger healthcare system?

SensiCardiac Mobi's mobile application and reliance on user-provided electronic stethoscopes suggest a potentially flexible rollout, with the ability to centralize multiple facilities on a user management system. The LINQ II, as a standardized insertable device with remote programming and monitoring infrastructure, is designed for scalability across various healthcare settings, supported by Medtronic's established presence and patient base.